期刊文献+

miR-21抑制替莫唑胺诱导U87细胞凋亡的体外实验研究 被引量:1

miR- 21 confers apoptosis resistance to temozolomide in glioblastoma U87 cells in vitro
原文传递
导出
摘要 目的探讨miR-21过表达在替莫唑胺诱导胶质瘤U87细胞凋亡中的作用及其机制。方法miR-21过表达载体转染U87细胞,Hoeehst33258染色和流式细胞分析凋亡,Westernblot验证Bax和Bcl-2表达及检测Caspase-3活性。结果替莫唑胺可显著诱导U87细胞凋亡,上调Bax表达、下调Bcl-2表达及增加Caspase-3活性。U87细胞预转染miR-21过表达载体后,替莫唑胺的这种效应可部分被抑制。结论miR-21过表达可通过下调Bax/Bcl-2比率及Caspase-3活性部分抑制替莫唑胺诱导的U87细胞凋亡,提示胶质瘤中miR-21过表达可能是胶质瘤对替莫唑胺耐药的g 大新的因素。 Objective To explore the function and mechanism of miR- 21 overexpression in glioblastoma U87 cells apoptosis induced by temozolomide (TMZ). Methods miR- 21 over- expression vectors were transfected into U87 cells. After that, cell apoptosis was analyzed by Hoeehst 33258 staining and flow cytometry. And the expression of Bax and Bcl - 2 was identified by Western blot, while Caspase - 3 activity was detected. Results TMZ could effectively induce the apoptosis of U87 cells, upregulate the Bax expression, downregulate the Bcl -2 expression and increase PI3K activity. However,after U87 ceils were pre -transfected with miR -21 over- expression vectors, the effects induced by TMZ was partly inhibited. Conclusion Over - expression miR - 21 could inhibit TMZ - induced apoptosis in U87 cells, at least in part,by decreasing Bax/Bcl- 2 ratio and Caspase- 3 activity, which highlighted the possibility of miR -21 overexpression in resistance to chemotherapy TMZ in glioblastomas.
出处 《中华神经外科杂志》 CSCD 北大核心 2012年第3期304-308,共5页 Chinese Journal of Neurosurgery
基金 基金项目:国家自然科学基金项目(81000963,81072078,30200335,30872657) 江苏省“333工程”培养资金资助项目(BRA2011046) 昆山社会发展项目基金(KS1006和KS1009) 苏州社会发展项目基金(SYS201063)
关键词 微RNAS 替莫唑胺 细胞凋亡 神经胶质瘤 MicroRNAs Temozolomide Apoptosis Glioma
  • 相关文献

参考文献11

二级参考文献100

共引文献56

同被引文献14

  • 1赵澎,张亚卓,孙梅珍.MDR1小干扰RNA调节人脑多形性胶质母细胞瘤细胞系BT325的药物敏感性[J].癌症,2005,24(12):1436-1441. 被引量:9
  • 2孙梅珍,赵澎,王红云,王钜,张亚卓.一种G422胶质母细胞瘤瘤株标准化动物模型的建立[J].中华实验外科杂志,2006,23(1):101-102. 被引量:5
  • 3Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev, 2007, 21 : 2683- 2710.
  • 4Zhao P, Zhang Y, Sun M, et al. Reversion of multidrug resistance in human glioma by RNA interference. Neurol Res, 2008, 30: 562- 566.
  • 5Jabir NR, Tabrez S, Ashraf GM, et al. Nanotechnology-based approaches in anticancer research. Int J Nanomedicine, 2012, 7:4391- 408.
  • 6James CD. Nanoparticles for treating brain tumors: unlimited possibilities. Neuro Oneol, 2012, 14 : 389.
  • 7Caruso G, Caffo M , Alafaci C , et al. Could nanoparticle systems have a role in the treatment of cerebral gliomas?. Nanomedicine, 2011, 7:744- 752.
  • 8Scherer F, Anton M, Schillinger U, et al. Magnetofection : enh- ancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther,2002, 9:102- 109.
  • 9Moore CB, Guthrie EH, Huang MT, et al. Short hairpin RNA ( shRNA ): design, delivery, and assessment of gene knockdown. Methods Mol Biol,2010, 629 : 141- 158.
  • 10韩磊,张安玲,岳晓,许鹏,杨旸,王广秀,贾志凡,浦佩玉,康春生.RNA干扰敲低Dicer对胶质瘤细胞恶性表型的影响[J].中华神经外科杂志,2011,27(2):131-135. 被引量:4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部